Risk of Venous Thromboembolism in Patients Receiving First-Line Chemotherapy for Disseminated Germ Cell Tumours

NCT04122430 · clinicaltrials.gov ↗
COMPLETED
Status
1135
Enrollment
OTHER
Sponsor class

Conditions

Interventions

Sponsor

Walter and Eliza Hall Institute of Medical Research

Collaborators